BriaCell Therapeutics (TSX:BCT) reveals new positive survival data in its Phase 2 metastatic breast cancer study.

Clinical-stage immuno-oncology company Imugene is celebrating more than two years’ “complete response” for one of its bile tract cancer trial...

Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of patients with stage 3...

Drugs aimed at HER2-positive breast cancer may also help certain patients with bile duct cancer, as indicated by findings from a patient trial that...

In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast...

Sharney Blackway, a mother from Boksburg East, Gauteng, has survived breast cancer twice, despite initial misdiagnoses.

As part of Breast Cancer Awareness Month in October, Bolt hosted a specialized wellness workshop for its female drivers. The workshop focused on the...

 As part of its commitment to promoting health and well-being, SUNU Nigeria – SUNU Assurances PLC and SUNU Health Nigeria Limited, is set to...

Tissue stiffness in HER2-negative breast cancer, the most common type, can directly contribute to disease progression and metastasis, which can have...